Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes (original) (raw)

Immunogenetics of Type 1 Diabetes

Rajni Rani

Autoimmune Disorders - Pathogenetic Aspects, 2011

View PDFchevron_right

Immunological biomarkers for the development and progression of type 1 diabetes

Timothy Tree

Diabetologia

View PDFchevron_right

Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus

Mie Afify

Bulletin of the National Research Centre

View PDFchevron_right

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

Jalal Taneera

Nature Genetics, 2010

View PDFchevron_right

The heterogeneous pathogenesis of type 1 diabetes mellitus

Jorma Ilonen

Nature Reviews Endocrinology, 2019

View PDFchevron_right

Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to Insulin-Dependent Diabetes Mellitus (IDDM)

Jørn Nerup

Cytokine, 1995

View PDFchevron_right

Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis

Bente Pedersen

Journal of Applied Physiology, 2006

View PDFchevron_right

Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes

Aurelian Bidulescu

Diabetes, 2013

View PDFchevron_right

Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus

David Klinke

PLoS ONE, 2008

View PDFchevron_right

Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in health

Michael Horowitz, Michelle Bound

Acta Diabetologica, 2014

View PDFchevron_right

Multicenter Prevention Trial of Slowly Progressive Type 1 Diabetes with Small Dose of Insulin (the Tokyo Study)

Azuma Kanatsuka

Annals of the New York Academy of Sciences, 2003

View PDFchevron_right

Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes

Isaac Sekitoleko

Diabetologia, 2022

View PDFchevron_right

Associations of β -Cell Function and Insulin Resistance with Youth-Onset Type 2 Diabetes and Prediabetes Among Asian Indians

Amutha Anandakumar

Diabetes Technology & Therapeutics, 2013

View PDFchevron_right

Type 1 diabetes in insulin-treated adult-onset diabetic subjects

Paul Zimmet

Diabetes Research and Clinical Practice, 1998

View PDFchevron_right

Immune State Assessment in People with Diabetes Mellitus

Mohammad J Al-Jassani

The Journal of communicable diseases, 2023

View PDFchevron_right

Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification

Ben Jones

2021

View PDFchevron_right

Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort

Jorma Ilonen

Diabetologia, 2001

View PDFchevron_right

A simple way to estimate mean plasma glucose and to identify Type�2 diabetic subjects with poor glycaemic control when a standardized HbA 1c assay is not available

Alpaslan Tuzcu

Diabetic Medicine, 2006

View PDFchevron_right

Serum IL-1ra Is Associated with but Has No Genetic Link to Type 1 Diabetes

Sharad Purohit

Endocrines

View PDFchevron_right

Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

ANDREA NATALI

Diabetologia, 2003

View PDFchevron_right

Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study

mitra hasheminia

Acta Diabetologica, 2015

View PDFchevron_right

Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis

Antero Kesaniemi

Journal of Clinical …, 2009

View PDFchevron_right

The Association between HbA1c, Fasting Glucose, 1-Hour Glucose and 2-Hour Glucose during an Oral Glucose Tolerance Test and Cardiovascular Disease in Individuals with Elevated Risk for Diabetes

Matti Uusitupa

PLoS ONE, 2014

View PDFchevron_right

Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities?

Paul Zimmet

Diabetes/Metabolism Research and Reviews, 2010

View PDFchevron_right

The Edinburgh Type 2 Diabetes Study: study protocol

Brian Frier

BMC Endocrine Disorders, 2008

View PDFchevron_right

International Journal of Diabetes and Clinical Research

Myron Szewczuk

View PDFchevron_right

Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP)

Jorma Ilonen

Scientific Reports, 2018

View PDFchevron_right

Type 1 Diabetes Mellitus-Associated Genetic Variants Contribute to Overlapping Immune Regulatory Networks

Mark Vickers

Frontiers in Genetics, 2018

View PDFchevron_right

Heterogeneity of glycaemic phenotypes in type 1 diabetes

Gloria Aguayo

Diabetologia, 2024

View PDFchevron_right

Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes

Jørn Nerup

Diabetologia, 1982

View PDFchevron_right

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study

Fabrizio Campi

Diabetes Care, 2020

View PDFchevron_right

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 277 Exploration of Conditions Affecting Cytokine Production in Experimental type 1 Diabetes Mellitus

Lina Thorvaldson

2007

View PDFchevron_right

Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes

Luc Van Gaal

Diabetologia, 2006

View PDFchevron_right

Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes

Adolpho Milech

Diabetes Research and Clinical Practice, 2007

View PDFchevron_right

The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)

Nanette Schloot

PLoS ONE, 2013

View PDFchevron_right